Acurx Pharmaceuticals Holds Annual Shareholder Meeting

• Acurx Pharmaceuticals shareholders elected David P. Luci and Jack H. Dean as directors at the October 16, 2026 annual meeting.
• Shareholders also ratified CohnReznick’s appointment as independent registered public accounting firm for the fiscal year ending December 31, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acurx Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-116632), on October 16, 2026, and is solely responsible for the information contained therein.